Syndax Pharmaceuticals, Inc. (SNDX) stock analysis

SNDX · Syndax Pharmaceuticals, Inc.

Latest recorded price: USD 9.13

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 7.3%, free cash flow margin -187.5%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare